160 related articles for article (PubMed ID: 23352007)
21. Living Donor Liver Transplantation for Patients With Hepatocellular Carcinoma: What Are the Optimal Criteria?
Sha M; Tong Y; Xia Q
Liver Transpl; 2021 Jun; 27(6):930-931. PubMed ID: 33539659
[No Abstract] [Full Text] [Related]
22. Living donor liver transplantation without the use of blood products.
Liu CL; Fan ST; Lo CM; Wei WI; Yong BH; Lai CL; Wong J
Hong Kong Med J; 2002 Jun; 8(3):192-5. PubMed ID: 12055365
[TBL] [Abstract][Full Text] [Related]
23. Living donor liver transplantation for hepatocellular carcinoma exceeding conventional criteria: questions, answers and demands for a common language.
Majno P; Mazzaferro V
Liver Transpl; 2006 Jun; 12(6):896-8. PubMed ID: 16721768
[No Abstract] [Full Text] [Related]
24. Living donor liver transplantation for hepatocellular carcinoma: altruism to the rescue.
Fisher RA
Liver Transpl; 2004 Mar; 10(3):448. PubMed ID: 15004775
[No Abstract] [Full Text] [Related]
25. Impact of a living donor liver transplant program for hepatocellular carcinoma to the running local deceased donor liver transplant program.
Sotiropoulos GC; Malagó M; Molmenti EP; Radtke A; Fouzas I; Beckebaum S; Saner FH; Paul A; Lang H; Broelsch CE
Dig Dis Sci; 2010 Mar; 55(3):872-3. PubMed ID: 19294504
[No Abstract] [Full Text] [Related]
26. [Living donor liver transplantation for hepatocellular carcinoma].
Ichida T
Nihon Shokakibyo Gakkai Zasshi; 2006 Feb; 103(2):149-55. PubMed ID: 16506662
[No Abstract] [Full Text] [Related]
27. Living Donor Liver Transplant for Hepatocellular Carcinoma.
Subramanian V; Chapman W
Ann Surg Oncol; 2019 Jun; 26(6):1594-1595. PubMed ID: 30937661
[No Abstract] [Full Text] [Related]
28. Selection of HCC patients for liver transplantation: the Milan criteria, Hangzhou criteria and beyond.
Fan ST
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):233-4. PubMed ID: 18522876
[No Abstract] [Full Text] [Related]
29. Living donor liver transplant for fibrolamellar hepatocellular carcinoma using a deceased donor graft to reconstruct inferior vena cava.
Slater K; Bak TE; Kam I; Wachs ME
Liver Transpl; 2004 Apr; 10(4):555-6. PubMed ID: 15048801
[TBL] [Abstract][Full Text] [Related]
30. Transplantation of liver grafts from living donors into adults.
Shaked A; Lucey MR
N Engl J Med; 2001 Sep; 345(12):923-4. PubMed ID: 11565532
[No Abstract] [Full Text] [Related]
31. Living donor liver transplantation for recurrent hepatocellular carcinoma.
Liu C; Frilling A; Sotiropoulos GC; Weber F; Nadalin S; Malago M; Broelsch CE
Transpl Int; 2005 Jul; 18(7):889. PubMed ID: 15948872
[No Abstract] [Full Text] [Related]
32. Advances and controversies in liver transplantation: hepatocellular cancer, viral hepatitis, and living donor liver transplantation in adults. AASLD/ILTS liver transplantation course. October 27, 2000.
Liver Transpl; 2000 Nov; 6(6 Suppl 2):S1-80. PubMed ID: 11142912
[No Abstract] [Full Text] [Related]
33. Living-donor liver transplantation for patients with hepatocellular carcinoma in Japan: Current situations and challenge.
Sugawara Y
Hepatobiliary Pancreat Dis Int; 2020 Feb; 19(1):1-2. PubMed ID: 31859046
[No Abstract] [Full Text] [Related]
34. Current status and issues of living donor liver transplantation for hepatocellular carcinoma.
Tanaka K; Yamada T
Chir Ital; 2005; 57(2):137-43. PubMed ID: 15916138
[No Abstract] [Full Text] [Related]
35. The role and limitation of living donor liver transplantation for hepatocellular carcinoma.
Lo CM; Fan ST; Liu CL; Chan SC; Wong J
Liver Transpl; 2004 Mar; 10(3):440-7. PubMed ID: 15004774
[TBL] [Abstract][Full Text] [Related]
36. Living-donor liver transplantation for hepatocellular carcinoma.
Kawasaki S
Hepatogastroenterology; 2002; 49(43):53-5. PubMed ID: 11941984
[TBL] [Abstract][Full Text] [Related]
37. Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence.
Han S; Yang JD; Sinn DH; Ko JS; Kim JM; Shin JC; Son HJ; Gwak MS; Joh JW; Kim GS
Transplantation; 2016 Sep; 100(9):1933-8. PubMed ID: 27362316
[TBL] [Abstract][Full Text] [Related]
38. The future challenge in the MELD era: how to match extended-use donors and sick recipients.
Ravaioli M; Grazi GL; Ercolani G; Cescon M; Pinna AD; Ballardini G
Transplantation; 2006 Oct; 82(7):987-8. PubMed ID: 17038919
[No Abstract] [Full Text] [Related]
39. Recurrent hepatocellular carcinoma after living donor liver transplantation: a preventable problem or an acceptable risk?
Sonnenday CJ
Ann Surg Oncol; 2010 Sep; 17(9):2262-3. PubMed ID: 20431956
[No Abstract] [Full Text] [Related]
40. Salvage live donor liver transplantation for a second recurrence of hepatocellular carcinoma.
Sotiropoulos GC; Treckmann JW; Molmenti EP; Schmitz KJ; Cicinnati VR; Paul A; Broelsch CE; Malagó M
Transpl Int; 2008 Feb; 21(2):182-5. PubMed ID: 17971034
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
